Diphtheria Market Size, Share, Growth, Trends And Forecast 2024-2033

Posted April 2, 2024 by Shraddhatbrc

It will grow to $11.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. 
Overview and Scope
Diphtheria is a bacterial illness caused by strains of bacteria called bacteria Corynebacterium diphtheriae which make a toxin that predominantly affects the mucous membranes of the throat and nose and can also affect other regions of the body in severe instances. It can be identified by throat discomfort, weakness, fever, swollen neck glands, breathing difficulties due to tissues clogging the nose and throat and difficulty in swallowing.

Sizing and Forecast
The diphtheria market size has grown strongly in recent years. It will grow from $8.34 billion in 2023 to $8.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to vaccine development, immunization campaigns, increased awareness, healthcare infrastructure.

The diphtheria market size is expected to see strong growth in the next few years. It will grow to $11.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.  The growth in the forecast period can be attributed to emerging outbreaks, booster vaccination programs, global travel and migration, public health preparedness. Major trends in the forecast period include combination vaccines, telemedicine for vaccination, vaccine equity initiatives, public-private partnerships.

To access more details regarding this report, visit the link:

Segmentation & Regional Insights
The diphtheria market covered in this report is segmented –
1) By Type: Diphtheria; Skin Diphtheria; Other Types
2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
3) By Treatment: Antibiotics; Antitoxin; Other Treatments
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users

Asia-Pacific was the largest region in the diphtheria market in 2023. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

Major Driver Impacting Market Growth
The rising prevalence of bacterial infections is expected to propel the growth of the diphtheria market going forward. A bacterial infection is a sickness or condition attributed to bacterial growth or the toxins produced by bacteria that invade the body. Diphtheria is a serious infection caused by bacteria strains that suppress the immune system and promote the proliferation of Corynebacterium diphtheria. For instance, in November 2022, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based public health organization, the number of reported infections of Acinetobacter species resistant to various antimicrobial groups was over doubled (+121%) the average in the year 2021 and more than 35,000 people die from antimicrobial-resistant infections in the EU each year. Furthermore, the number of Klebsiella pneumonia cases increased by 31% in 2020 and another 20% in the year 2021. Therefore, the rising prevalence of bacterial infections will drive the diphtheria market.

Key Industry Players
Major players in the diphtheria market are  Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

The diphtheria market report table of contents includes:
1. Executive Summary
2. Diphtheria Market Characteristics
3. Diphtheria Market Trends And Strategies
4. Diphtheria Market - Macro Economic Scenario
5. Global Diphtheria Market Size and Growth
32. Global Diphtheria Market Competitive Benchmarking
33. Global Diphtheria Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Diphtheria Market
35. Diphtheria Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Shraddha
Country United States
Categories Health , Medical , Reports
Tags diphtheria market , diphtheria market size , diphtheria market share , diphtheria market forecast , diphtheria market analysis
Last Updated April 2, 2024